Shares of Becton Dickinson & Co. bounced back Wednesday toward their first gain in seven sessions after the Food and Drug Administration addressed supply issues surrounding blood-culture vials.
Becton Dickinson’s stock bounces as FDA addresses supply issue with blood-culture vials
